Abstract:Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) belongs to the Beta-coronavirus genus. It is 96.2% homologous to bat CoV RaTG13 and 88% homologous to two bat SARS-like coronaviruses. SARS-CoV-2 is the infectious agent responsible for the coronavirus disease (COVID-19), which was first reported in the Hubei province of Wuhan, China, at the beginning of December 2019. Human transmission from COVID-19 patients or incubation carriers occurs via coughing, sneezing, speaking, discharge from the nose, or fecal contamination. Various strains of the virus have been reported around the world, with different virulence and behavior. In addition, SARS-CoV-2 shares certain epitopes with some taxonomically related viruses, with tropism for the most common synanthropic animals. By elucidating the immunological properties of the circulating SARS-CoV-2, a partial protection due to human-animal interactions could be supposed in some situations. In addition, differential epitopes could be used for the differential diagnosis of SARS-CoV-2 infection. There have been cases of transmission from people with COVID-19 to pets such as cats and dogs. In addition, wild felines were infected. All These animals were either asymptomatic or mildly symptomatic and recovered spontaneously. Experimental studies showed cats and ferrets to be more susceptible to COVID-19. COVID-19 positive dogs and felines do not transmit the infection to humans. In contrast, minks at farms were severely infected from people with COVID-19. A SARS-Cov-2 variant in the Danish farmed mink that had been previously infected by COVID-19 positive workers, spread to mink workers causing the first case of animal-to-human infection transmission that causes a moderate decreased sensitivity to neutralizing antibodies. Thus, more investigations are necessary. It remains important to understand the risk that people with COVID-19 pose to their pets, as well as wild or farm animals so effective recommendations and risk management measures against COVID-19 can be made. A One Health unit that facilitates collaboration between public health and veterinary services is recommended.

SARS‐CoV‐2 and Natural Infection in Animals

An Overview of SARS-CoV-2 and Animal Infection

SARS CoV-2 infections in animals, two years into the pandemic

Evidence for SARS-CoV-2 Infection of Animal Hosts

Current Status of Putative Animal Sources of SARS-CoV-2 Infection in Humans: Wildlife, Domestic Animals and Pets

COVID-19 and One Health: potential role of human and animals in SARS-CoV-2 life cycle

Natural infections of SARS‐CoV‐2 increased in animals: How should humans interact with animals?

Host Diversity and Potential Transmission Pathways of SARS-CoV-2 at the Human-Animal Interface

Cross-species transmission of coronaviruses with a focus on severe acute respiratory syndrome coronavirus 2 infection in animals: a review for the veterinary practitioner

SARS-CoV-2 Infections in Animals: Reservoirs for Reverse Zoonosis and Models for Study

SARS-CoV-2 host diversity: An update of natural infections and experimental evidence

Do Animals Play a Role in the Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)? A Commentary

Breaking the Barrier: SARS-CoV-2 Infections in Wild and Companion Animals and Their Implications for Public Health

Severe acute respiratory syndrome coronavirus-2 natural animal reservoirs and experimental models: systematic review

Reverse zoonosis of coronavirus disease-19: Present status and the control by one health approach

SARS-CoV-2 in animals: what about the cat?

SARS-CoV-2 infection of domestic animals and their role in evolution and emergence of variants of concern

Risk assessment of SARS-CoV-2 replicating and evolving in animals

SARS-CoV-2 immunity in animal models

An overview of SARS‐CoV2 natural infections in companion animals: A systematic review of the current evidence

Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2